TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
Revolution Medicines, Inc.
Seagen Inc.
Eli Lilly and Company
Pfizer
City of Hope Medical Center
Novartis
Medicine Invention Design, Inc
Amal Therapeutics